Tang Capital Management as of Sept. 30, 2022
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 95 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Anaptysbio Inc Common (ANAB) | 8.2 | $67M | 2.6M | 25.51 | |
| Biohaven Pharmaceutical Holding | 5.2 | $42M | 280k | 151.17 | |
| Bluebird Bio (BLUE) | 4.9 | $40M | 6.3M | 6.33 | |
| Tarsus Pharmaceuticals (TARS) | 4.4 | $36M | 2.1M | 17.12 | |
| Altimmune Com New (ALT) | 4.1 | $33M | 2.6M | 12.77 | |
| Intra Cellular Therapies (ITCI) | 3.7 | $30M | 640k | 46.53 | |
| Heron Therapeutics (HRTX) | 3.5 | $29M | 6.8M | 4.22 | |
| Bio Rad Labs Cl A (BIO) | 3.3 | $27M | 64k | 417.14 | |
| Kalvista Pharmaceuticals (KALV) | 3.2 | $26M | 1.8M | 14.51 | |
| Albireo Pharma | 2.6 | $21M | 1.1M | 19.36 | |
| Rocket Pharmaceuticals (RCKT) | 2.5 | $20M | 1.3M | 15.96 | |
| Alnylam Pharmaceuticals (ALNY) | 2.5 | $20M | 100k | 200.16 | |
| Immunocore Hldgs Ads (IMCR) | 2.3 | $19M | 406k | 46.94 | |
| Miragen Therapeutics (VRDN) | 2.2 | $18M | 883k | 20.51 | |
| Iteos Therapeutics (ITOS) | 2.2 | $18M | 938k | 19.05 | |
| Bioatla (BCAB) | 1.9 | $15M | 2.0M | 7.70 | |
| BioCryst Pharmaceuticals (BCRX) | 1.9 | $15M | 1.2M | 12.60 | |
| Relmada Therapeutics (RLMD) | 1.8 | $15M | 400k | 37.02 | |
| Beigene Sponsored Adr (BGNE) | 1.7 | $14M | 105k | 134.82 | |
| Harmony Biosciences Hldgs In (HRMY) | 1.7 | $14M | 310k | 44.29 | |
| 1.6 | $13M | 300k | 43.84 | ||
| Female Health (VERU) | 1.6 | $13M | 1.1M | 11.52 | |
| Insmed Com Par $.01 (INSM) | 1.3 | $11M | 500k | 21.54 | |
| Galapagos Nv Spon Adr (GLPG) | 1.2 | $9.6M | 225k | 42.64 | |
| Mirum Pharmaceuticals (MIRM) | 1.2 | $9.5M | 450k | 21.01 | |
| Ionis Pharmaceuticals (IONS) | 1.1 | $8.8M | 200k | 44.23 | |
| Nkarta (NKTX) | 1.1 | $8.7M | 663k | 13.16 | |
| Astrazeneca Sponsored Adr (AZN) | 1.0 | $8.2M | 150k | 54.84 | |
| Allakos (ALLK) | 1.0 | $8.1M | 1.3M | 6.12 | |
| Day One Biopharmaceuticals I (DAWN) | 1.0 | $8.0M | 400k | 20.03 | |
| Cullinan Oncology (CGEM) | 1.0 | $8.0M | 624k | 12.82 | |
| Revance Therapeutics (RVNC) | 1.0 | $7.8M | 288k | 27.00 | |
| Kiniksa Pharmaceuticals Com Cl A | 0.9 | $7.7M | 600k | 12.84 | |
| Coherus Biosciences (CHRS) | 0.9 | $7.2M | 750k | 9.61 | |
| ImmunoGen | 0.9 | $7.2M | 1.5M | 4.78 | |
| Enanta Pharmaceuticals (ENTA) | 0.9 | $7.1M | 138k | 51.87 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $6.8M | 66k | 103.25 | |
| Tcr2 Therapeutics Inc cs | 0.8 | $6.7M | 3.7M | 1.80 | |
| Concert Pharmaceuticals I equity | 0.8 | $6.7M | 1.0M | 6.70 | |
| Bridgebio Pharma (BBIO) | 0.7 | $5.8M | 585k | 9.94 | |
| Arcus Biosciences Incorporated (RCUS) | 0.6 | $5.2M | 200k | 26.16 | |
| Cytomx Therapeutics (CTMX) | 0.6 | $5.1M | 3.5M | 1.45 | |
| Celldex Therapeutics Com New (CLDX) | 0.6 | $4.5M | 160k | 28.11 | |
| Genfit S A Ads (GNFT) | 0.5 | $4.4M | 1.2M | 3.65 | |
| 2seventy Bio Common Stock (TSVT) | 0.5 | $4.4M | 300k | 14.55 | |
| Biontech Se Sponsored Ads (BNTX) | 0.5 | $4.0M | 30k | 134.87 | |
| Alibaba Group Hldg Sponsored Ads (BABA) | 0.5 | $4.0M | 50k | 80.00 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.5 | $3.9M | 393k | 9.90 | |
| Aldeyra Therapeutics (ALDX) | 0.5 | $3.7M | 700k | 5.34 | |
| Fortress Biotech | 0.4 | $3.6M | 4.2M | 0.86 | |
| Graphite Bio | 0.4 | $3.5M | 1.1M | 3.17 | |
| Springworks Therapeutics (SWTX) | 0.4 | $3.4M | 120k | 28.53 | |
| Aslan Pharmaceuticals Ads | 0.4 | $3.4M | 5.7M | 0.60 | |
| Esperion Therapeutics (ESPR) | 0.4 | $3.4M | 500k | 6.70 | |
| Atyr Pharma Com New (ATYR) | 0.4 | $3.3M | 1.1M | 3.00 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.4 | $3.3M | 50k | 65.36 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.4 | $3.3M | 80k | 40.80 | |
| Biosante Pharmaceuticals (ANIP) | 0.4 | $3.2M | 100k | 32.14 | |
| Eagle Pharmaceuticals (EGRX) | 0.4 | $3.1M | 119k | 26.42 | |
| Axsome Therapeutics (AXSM) | 0.4 | $3.1M | 70k | 44.61 | |
| Clene Common Stock (CLNN) | 0.4 | $3.1M | 1.1M | 2.80 | |
| Gossamer Bio (GOSS) | 0.4 | $3.0M | 250k | 11.98 | |
| Pyxis Oncology Common Stock (PYXS) | 0.3 | $2.8M | 1.4M | 1.97 | |
| Blueprint Medicines (BPMC) | 0.3 | $2.6M | 40k | 65.90 | |
| Chemocentryx | 0.3 | $2.6M | 50k | 51.66 | |
| Vanda Pharmaceuticals (VNDA) | 0.3 | $2.5M | 257k | 9.88 | |
| Adma Biologics (ADMA) | 0.3 | $2.4M | 993k | 2.43 | |
| Beam Therapeutics (BEAM) | 0.3 | $2.4M | 50k | 47.64 | |
| Silverback Therapeutics (SPRY) | 0.3 | $2.2M | 410k | 5.28 | |
| Bellus Health Com New | 0.3 | $2.1M | 200k | 10.56 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.2 | $2.0M | 259k | 7.76 | |
| Aligos Therapeutics (ALGS) | 0.2 | $1.8M | 1.7M | 1.10 | |
| Cti Biopharma | 0.2 | $1.7M | 300k | 5.82 | |
| Tscan Therapeutics (TCRX) | 0.2 | $1.7M | 558k | 3.05 | |
| Aurinia Pharmaceuticals (AUPH) | 0.2 | $1.5M | 200k | 7.52 | |
| Inspirato Incorporated Com Cl A | 0.2 | $1.4M | 612k | 2.36 | |
| Vincerx Pharma Com New (VINC) | 0.2 | $1.4M | 1.0M | 1.38 | |
| Mirati Therapeutics | 0.2 | $1.4M | 20k | 69.85 | |
| Nektar Therapeutics (NKTR) | 0.2 | $1.4M | 430k | 3.20 | |
| Equillium (EQ) | 0.2 | $1.3M | 600k | 2.22 | |
| Tritium Dcfc Ordinary Shares | 0.2 | $1.3M | 400k | 3.19 | |
| Leap Therapeutics | 0.1 | $1.1M | 1.3M | 0.88 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.1 | $1.0M | 100k | 10.44 | |
| Orchard Therapeutics Spon Ads | 0.1 | $1.0M | 2.0M | 0.50 | |
| Alector (ALEC) | 0.1 | $946k | 100k | 9.46 | |
| Pardes Biosciences | 0.1 | $925k | 500k | 1.85 | |
| Arvinas Ord (ARVN) | 0.1 | $890k | 20k | 44.50 | |
| Olema Pharmaceuticals (OLMA) | 0.1 | $880k | 319k | 2.76 | |
| Metacrine Ord | 0.1 | $833k | 1.7M | 0.48 | |
| Homology Medicines | 0.0 | $346k | 215k | 1.61 | |
| Bolt Biotherapeutics (BOLT) | 0.0 | $296k | 200k | 1.48 | |
| Evolus (EOLS) | 0.0 | $294k | 37k | 8.05 | |
| Molecular Partners Ads (MOLN) | 0.0 | $105k | 16k | 6.70 | |
| Inspirato Incorporated *w Exp 02/11/2027 (ISPOW) | 0.0 | $88k | 365k | 0.24 | |
| Acelrx Pharmaceuticals | 0.0 | $81k | 389k | 0.21 |
